285 related articles for article (PubMed ID: 10050141)
1. [All mortality by cause of death. The challenge of coronary prevention].
Fernández-Cruz A
Rev Esp Cardiol; 1998; 51 Suppl 6():23-9. PubMed ID: 10050141
[TBL] [Abstract][Full Text] [Related]
2. Meta-analysis, clinical trials, and transferability of research results into practice. The case of cholesterol-lowering interventions in the secondary prevention of coronary heart disease.
Marchioli R; Marfisi RM; Carinci F; Tognoni G
Arch Intern Med; 1996 Jun; 156(11):1158-72. PubMed ID: 8639010
[TBL] [Abstract][Full Text] [Related]
3. [Statins in primary prevention of coronary heart disease].
Paulweber B
Wien Med Wochenschr; 1999; 149(5-6):129-38. PubMed ID: 10408004
[TBL] [Abstract][Full Text] [Related]
4. Cholesterol, coronary heart disease and stroke: a review of published evidence from observational studies and randomized controlled trials.
Huxley R; Lewington S; Clarke R
Semin Vasc Med; 2002 Aug; 2(3):315-23. PubMed ID: 16222621
[TBL] [Abstract][Full Text] [Related]
5. Relationship between low cholesterol and disease. Evidence from epidemiological studies and preventive trials.
Epstein FH
Ann N Y Acad Sci; 1995 Jan; 748():482-90. PubMed ID: 7695190
[TBL] [Abstract][Full Text] [Related]
6. Statins for primary and secondary prevention of coronary heart disease. A scientific review.
Carneiro AV; Costa J; Borges M
Rev Port Cardiol; 2004 Jan; 23(1):95-122. PubMed ID: 15058150
[TBL] [Abstract][Full Text] [Related]
7. [Cardiovascular risk factors and prevention in women: similarities and differences].
Sclavo M
Ital Heart J Suppl; 2001 Feb; 2(2):125-41. PubMed ID: 11255880
[TBL] [Abstract][Full Text] [Related]
8. The benefits of reducing cholesterol levels: the need to distinguish primary from secondary prevention. 1. A meta-analysis of cholesterol-lowering trials.
Silberberg JS; Henry DA
Med J Aust; 1991 Nov; 155(10):665-6, 669-70. PubMed ID: 1834922
[TBL] [Abstract][Full Text] [Related]
9. Consistency of lipid-altering effects of ezetimibe/simvastatin across gender, race, age, baseline low density lipoprotein cholesterol levels, and coronary heart disease status: results of a pooled retrospective analysis.
Ose L; Shah A; Davies MJ; Rotonda J; Maccubbin D; Tribble D; Veltri E; Mitchel Y
Curr Med Res Opin; 2006 May; 22(5):823-35. PubMed ID: 16709304
[TBL] [Abstract][Full Text] [Related]
10. Cholesterol: precursor to many lipid disorders.
Jones PH
Am J Manag Care; 2001 Aug; 7(9 Suppl):S289-98. PubMed ID: 11517815
[TBL] [Abstract][Full Text] [Related]
11. Cost-benefit analysis of a plant sterol containing low-fat margarine for cholesterol reduction.
Gerber A; Evers T; Haverkamp H; Lauterbach KW
Eur J Health Econ; 2006 Dec; 7(4):247-54. PubMed ID: 16821072
[TBL] [Abstract][Full Text] [Related]
12. [Is there a relationship between cholesterol reduction, low levels of cholesterol and mortality?].
LaRosa JC
Rev Esp Cardiol; 1995; 48 Suppl 2():14-7. PubMed ID: 7569270
[TBL] [Abstract][Full Text] [Related]
13. Does lowering serum cholesterol levels lower coronary heart disease risk?
Rossouw JE; Rifkind BM
Endocrinol Metab Clin North Am; 1990 Jun; 19(2):279-97. PubMed ID: 2192874
[TBL] [Abstract][Full Text] [Related]
14. New therapeutic options in the National Cholesterol Education Program Adult Treatment Panel III.
Talbert RL
Am J Manag Care; 2002 Sep; 8(12 Suppl):S301-7. PubMed ID: 12240701
[TBL] [Abstract][Full Text] [Related]
15. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
Chin Med J (Engl); 2004 Feb; 117(2):163-7. PubMed ID: 14975195
[TBL] [Abstract][Full Text] [Related]
16. [Optimal serum cholesterol and efficacy of methods for lowering cholesterolemia].
Emmerich J; Thomas D; Richard JL; Delahaye F; Bruckert E
Arch Mal Coeur Vaiss; 1992 Oct; 85 Spec No 3():59-65. PubMed ID: 1296546
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of statin therapy in adults with coronary heart disease.
Wilt TJ; Bloomfield HE; MacDonald R; Nelson D; Rutks I; Ho M; Larsen G; McCall A; Pineros S; Sales A
Arch Intern Med; 2004 Jul; 164(13):1427-36. PubMed ID: 15249352
[TBL] [Abstract][Full Text] [Related]
18. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
19. [Cholesterolemia control in Spain, 2000. A tool for cardiovascular disease prevention. Ministry of Health and Consumption, Spanish Society of Cardiology and Spanish Society of Arteriosclerosis].
Rev Esp Salud Publica; 2000; 74(3):215-53. PubMed ID: 10918811
[TBL] [Abstract][Full Text] [Related]
20. What do we gain by modifying risk factors for coronary disease?
Mitchell JR
Schweiz Med Wochenschr; 1990 Mar; 120(11):359-64. PubMed ID: 2181641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
